Skip to main content
TipRanks
Go Ultimate75% OFF

Citius Pharmaceuticals (CTXR) Ratios

1,811 Followers

Citius Pharmaceuticals Ratios

CTXR's free cash flow for Q3 2026 was $-8.68M. For the 2026 fiscal year, CTXR's free cash flow was increased by $0.00 and operating cash flow was $-8.68M. See a summary of the company’s cash flow.

Financial ratios
RatiosSep 25Sep 24Dec 23Sep 22Sep 21
Liquidity Ratios
Current Ratio0.620.405.959.8418.28
Quick Ratio0.130.175.959.8418.28
Cash Ratio0.090.094.589.2117.60
Solvency Ratio-0.70-0.91-2.66-3.16-2.38
Operating Cash Flow Ratio-0.59-0.79-5.03-6.26-6.09
Short-Term Operating Cash Flow Coverage-26.55-116.75-133.07-143.97-136.82
Net Current Asset Value$ -25.48M$ -28.33M$ 22.19M$ 33.99M$ 63.17M
Leverage Ratios
Debt-to-Assets Ratio0.010.000.000.010.01
Debt-to-Equity Ratio0.030.000.010.010.01
Debt-to-Capital Ratio0.030.000.010.010.01
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.941.661.141.111.08
Debt Service Coverage Ratio-30.97-162.35-148.13-74.63-121.65
Interest Coverage Ratio-143.870.000.00-132.52-2171.04
Debt to Market Cap0.070.000.000.000.00
Interest Debt Per Share0.190.020.050.100.12
Net Debt to EBITDA0.060.080.821.253.03
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT96.77%100.74%101.80%101.74%100.31%
EBT Per EBIT100.41%92.51%87.03%99.25%97.97%
Return on Assets (ROA)-28.59%-33.55%-31.41%-29.51%-16.24%
Return on Equity (ROE)-55.42%-55.85%-35.83%-32.72%-17.49%
Return on Capital Employed (ROCE)-44.79%-51.95%-37.55%-30.43%-17.00%
Return on Invested Capital (ROIC)-44.23%-51.64%-37.38%-30.33%-16.95%
Return on Tangible Assets-130.02%-269.83%-93.34%-74.34%-31.39%
Earnings Yield-272.82%-26.97%-19.52%-11.42%-6.29%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.020.040.070.150.13
Inventory Turnover0.010.030.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle14639.185818.72-5498.66-2367.38-2827.35
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding37968.0014398.570.000.000.00
Days of Payables Outstanding23328.818579.865498.662367.382827.35
Operating Cycle37968.0014398.570.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-2.40-2.43-2.98-2.91-3.35
Free Cash Flow Per Share-2.40-2.43-2.98-2.91-8.88
Dividend Paid and CapEx Coverage Ratio0.000.000.000.00-0.61
Capital Expenditure Coverage Ratio0.000.000.000.00-0.61
Operating Cash Flow Coverage Ratio-14.64-107.28-60.39-41.82-28.35
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-193.52%-19.43%-17.43%-9.63%-17.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.37-3.71-5.12-8.76-15.89
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio0.202.071.842.872.78
Price-to-Free Cash Flow (P/FCF) Ratio-0.52-5.15-5.74-10.39-5.72
Price-to-Operating Cash Flow Ratio-0.52-5.15-5.74-10.39-15.15
Price-to-Earnings Growth (PEG) Ratio0.01-0.521.55-4.12-0.01
Enterprise Value Multiple-0.30-3.68-4.43-7.71-13.03
Enterprise Value11.28M142.12M140.68M253.57M298.21M
EV to EBITDA-0.30-3.68-4.43-7.71-13.03
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-0.42-5.04-4.84-8.94-4.64
EV to Operating Cash Flow-0.42-5.04-4.84-8.94-12.30
Tangible Book Value Per Share-2.22-2.422.333.568.84
Shareholders’ Equity Per Share6.106.059.3210.5618.26
Tax and Other Ratios
Effective Tax Rate-0.03-0.01-0.02-0.020.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-3.38-3.38-3.34-3.45-3.19
Tax Burden0.971.011.021.021.00
Interest Burden1.011.001.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.670.720.890.841.05

Currency in USD